Alza Ionsys resubmission
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
J&J subsidiary Alza resubmits its patient-controlled transdermal analgesic Ionsys (fentanyl) Nov. 28. The firm expects a six-month review, giving the iontophoresis product a May 28, 2006 action date. Ionsys had been "approvable" since July 2004...